论文部分内容阅读
Objective To study clinical characteristics of refractory or relapsed DNMT3A+cytogenetically normal acute myeloid leukemia(CN-AML)patients,and to explore the overall response rate(ORR)and side effects of these patients followed the therapy including decitabine with
Objective To study the clinical characteristics of refractory or relapsed DNMT3A + cytogenetically normal acute myeloid leukemia (CN-AML) patients, and to explore the overall response rate (ORR) and side effects of these patients followed the therapy including decitabine with